shRNA for inhibiting Japanese encephalitis virus replication and infection and application thereof
A Japanese encephalitis virus and expression plasmid technology, applied in the field of shRNA, to achieve the effect of treating JEV infection, reducing morbidity and mortality, and preventing JEV infection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0029] The preparation of embodiment 1 shRNA
[0030] (1) Design and synthesis of oligonucleotides
[0031] Taking JEV's E, NS3, NS4b gene mRNA sequence as the target sequence ( figure 1), using Ambion’s siRNA design software, through homology analysis, respectively designed and synthesized 4 for 1553-1571bp (E1), 1679-1697bp (E2), 6083-6101bp (NS3) and 7350-7368bp (NS4b) of the JEV gene for shRNA oligonucleotide strands. TTCAAGAGA is selected for its loop structure to avoid the formation of termination signal, and the transcription termination sequence of shRNA adopts T6 structure. CACC is added to the 5' end of the sense strand template, which is complementary to the sticky end formed after digestion with BbsI; GATC is added to the 5' end of the antisense strand template, which is complementary to the sticky end formed after digestion with BamHI; if the target sequence of shRNA If the first base is not G, a G is added after the CACC of the template strand. The template ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 